ATC code B06

ATC code B06 Other hematological agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2] Subgroup B06 is part of the anatomical group B Blood and blood forming organs.[3]

ATC codes
B Blood and blood forming organs
B01 Antithrombotic agents
B02 Antihemorrhagics
B03 Antianemic preparations
B05 Blood substitutes and perfusion solutions
B06 Other hematological agents

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QB06.[4]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

B06A Other hematological agentsEdit

B06AA EnzymesEdit

B06AA02 Fibrinolysin and desoxyribonuclease
B06AA03 Hyaluronidase
B06AA04 Chymotrypsin
B06AA07 Trypsin
B06AA10 Desoxyribonuclease
B06AA55 Streptokinase, combinations

B06AB Heme productsEdit

B06AB01 Hemin

B06AC Drugs used in hereditary angioedemaEdit

B06AC01 C1-inhibitor, plasma derived
B06AC02 Icatibant
B06AC03 Ecallantide
B06AC04 Conestat alfa
B06AC05 Lanadelumab

B06AX Other hematological agentsEdit

B06AX01 Crizanlizumab
B06AX02 Betibeglogene autotemcel

ReferencesEdit

  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 2020-02-01.
  2. ^ "ATC-Klassifikation mit definierten Tagesdosen DDD" (in German). German Institute for Medical Documentation and Information. Retrieved 2020-02-01.
  3. ^ "ATC/DDD Index 2021: code B06". WHO Collaborating Centre for Drug Statistics Methodology.
  4. ^ "ATCvet Index 2021: code QB06". WHO Collaborating Centre for Drug Statistics Methodology.